We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
AUM
$61M
AUM Growth
-$5.18M
Cap. Flow
-$9.62M
Cap. Flow %
-15.78%
Top 10 Hldgs %
40.21%
Holding
93
New
23
Increased
18
Reduced
20
Closed
29

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.7M
2
AMZN icon
Amazon
AMZN
+$1.55M
3
SCHW
Charles Schwab
SCHW
+$1.47M
4
BABA icon
Alibaba
BABA
+$1.38M
5
SYF icon
Synchrony
SYF
+$1.03M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.87M
2
UNH icon
UnitedHealth
UNH
+$2.81M
3
HCA icon
HCA Healthcare
HCA
+$2.53M
4
GILD icon
Gilead Sciences
GILD
+$2.26M
5
LLY icon
Eli Lilly
LLY
+$1.84M

Sector Composition

Rank Sector Weight
1 Healthcare 51.04%
2 Technology 8.38%
3 Industrials 7.42%
4 Financials 7.32%
5 Communication Services 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
76
PUT
Merck
MRK
$318B
-24,418
Closed -$31K
MTG icon
77
MGIC Investment
MTG
$6.25B
-67,750
Closed -$627K
PEN icon
78
Penumbra
PEN
$12.8B
-8,986
Closed -$360K
PFE icon
79
CALL
Pfizer
PFE
$153B
-52,278
Closed -$6K
PFE icon
80
Pfizer
PFE
$153B
-96,289
Closed -$2.87M
PTCT icon
81
CALL
PTC Therapeutics
PTCT
$6.12B
-9,900
Closed -$30K
ROK icon
82
CALL
Rockwell Automation
ROK
$49B
-6,400
Closed -$1K
TEVA icon
83
CALL
Teva Pharmaceuticals
TEVA
$41.2B
-53,000
Closed -$20K
RDUS
84
DELISTED
Radius Health, Inc.
RDUS
-10,703
Closed -$742K
AIMT
85
DELISTED
Aimmune Therapeutics
AIMT
-22,796
Closed -$577K
AGN
86
CALL
DELISTED
Allergan plc
AGN
-6,600
Closed -$53K
FOMX
87
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
-10,893
Closed -$80K
KERX
88
DELISTED
Keryx Biopharmaceuticals Inc
KERX
-2,313
Closed -$8K
BRCM
89
DELISTED
BROADCOM CORP CL-A
BRCM
-20,985
Closed -$1.08M
THOR
90
DELISTED
THORATEC CORPORATION
THOR
-10,500
Closed -$664K
BCR
91
DELISTED
CR Bard Inc.
BCR
-1,882
Closed -$351K
LNKD
92
DELISTED
LinkedIn Corporation
LNKD
-2,508
Closed -$477K

Similar funds

Partner Investment Management's Q4 2015 Portfolio in Review

As of Q4 2015, Partner Investment Management held 93 positions worth $61M, down 7.8% from $66.2M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Partner Investment Management withdrew a net $9.62M in Q4 2015, closing 29 positions and reducing 20 holdings. Its most notable exit was Pfizer, an estimated $2.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 61% a quarter earlier, followed by Technology and Industrials.

Against the trend, Partner Investment Management opened a new position in Alphabet (Google) Class A worth $1.79M.

  • Partner Investment Management's largest Q4 2015 buy was Alphabet (Google) Class A: 45,960 shares worth $1.79M.
  • Partner Investment Management added most to Bristol-Myers Squibb in Q4 2015, an estimated $944K increase.
  • Partner Investment Management's biggest Q4 2015 reduction was UnitedHealth, cutting an estimated $2.81M.
  • Partner Investment Management fully exited Pfizer in Q4 2015, selling an estimated $2.87M.
  • Partner Investment Management's ten largest holdings make up 40% of its $61M portfolio in Q4 2015.
  • Partner Investment Management opened 23 new positions and closed 29 in Q4 2015.
  • Partner Investment Management's portfolio value fell 7.8% quarter-over-quarter to $61M.

Based on Partner Investment Management's 13F filing for Q4 2015, filed 16 Feb 2016.